Efficacy of pegylated interferon plus ribavirin in combination with corticosteroid for two cases of combined hepatitis C and autoimmune hepatitis

The treatment strategy for cases of combined autoimmune hepatitis (AIH) and chronic hepatitis C (CHC) has not yet been established. A 47-year-old woman and a 53-year-old-woman were hospitalized for treatment of CHC. Ultrasonography and histological findings revealed that their liver was not cirrhoti...

Descripción completa

Detalles Bibliográficos
Autores principales: Oeda, Satoshi, Mizuta, Toshihiko, Isoda, Hiroshi, Kuwashiro, Takuya, Oza, Noriko, Iwane, Shinji, Takahashi, Hirokazu, Kawaguchi, Yasunori, Eguchi, Yuichiro, Toda, Shuji, Ozaki, Iwata, Anzai, Keizo, Fujimoto, Kazuma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Japan 2012
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3328672/
https://www.ncbi.nlm.nih.gov/pubmed/22593772
http://dx.doi.org/10.1007/s12328-012-0295-4
Descripción
Sumario:The treatment strategy for cases of combined autoimmune hepatitis (AIH) and chronic hepatitis C (CHC) has not yet been established. A 47-year-old woman and a 53-year-old-woman were hospitalized for treatment of CHC. Ultrasonography and histological findings revealed that their liver was not cirrhotic but did have chronic damage. The histological findings of both patients were suggestive of AIH. The patients were systematically treated with pegylated interferon-alpha 2b plus ribavirin which was preceded by and combined with corticosteroid (CS), and showed sustained virological responses and normal liver function. Although these two patients with combined AIH and CHC were successfully treated with this regimen, careful attention to exacerbation of hepatic inflammation is needed because hepatitis C viral load was increased due to immunosuppression during CS treatment.

Ejemplares similares